1. Abbassi, V., Linscheid, T., & Coleman, M. (1978). Triiodothyronine (T3) concentration and therapy in autistic children. Journal of Autism and Childhood Schizophrenia, 8, 383–387.
2. Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in infantile autism: Effects on learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195–1202.
3. August, G. J., Raz, N., & Baird, T. D. (1985). Brief report: Effects of fenfluramine on behavioral, cognitive, and affective disturbances in autistic children. Journal of Autism and Developmental Disorders, 15, 97–107.
4. Bernstein, G. A., Hughes, J. R., & Thompson, T. (1984, October 13). Naloxone reduces the self-injurious behavior of a mentally retarded adolescent. Paper presented at the Annual Meeting of the American Academy of Child Psychiatry, Toronto.
5. Campbell, M. (1985, July). Naltrexone in autistic children. Paper presented at the Autism Research Symposium, Seventh Annual Meeting and Conference of the National Society for Children and Adults with Autism, Los Angeles.